GoodRx Holdings Inc. (NASDAQ:GDRX), a leading healthcare technology company specializing in prescription drug discounts and telehealth services, finds itself at a critical juncture. As the company ...
GoodRx (GDRX) is joining in on the GLP-1 action with an announcement on Monday that it will begin selling both of Novo Nordisk's (NVO) GLP-1 drugs, Ozempic for diabetes and Wegovy for weight loss, at ...
GoodRx Holdings Inc (NASDAQ:GDRX) shares are pulling back Tuesday morning, as investors potentially take profits following Monday’s surge. The stock had jumped over 30% Monday after the company ...
Shares of healthcare tech company GoodRx (NASDAQ:GDRX) fell 1.7% in the afternoon session after Barclays initiated coverage on the health-focused technology company with an "Underweight" rating and a ...
Across the recent three months, 4 analysts have shared their insights on GoodRx Holdings (NASDAQ:GDRX), expressing a variety of opinions spanning from bullish to bearish. The table below provides a ...
Leerink Partners analyst Michael Cherny has reiterated their bullish stance on GDRX stock, giving a Buy rating on November 13. Don't Miss our Black Friday Offers: Unlock your investing potential with ...
Shareholders of Santa Monica-based GoodRx Holdings Inc. have undergone a considerable amount of pain as the digital health care company goes through a ...
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lessened its position in shares of GoodRx Holdings, Inc. (NASDAQ:GDRX – Free Report) by 17.6% during the fourth quarter, HoldingsChannel reports. The ...